Leuthold Group LLC reduced its position in McKesson Co. (NYSE:MCK – Free Report) by 0.9% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,907 shares of the company’s stock after selling 161 shares during the quarter. McKesson comprises about 1.2% of Leuthold Group LLC’s holdings, making the stock its 21st biggest holding. Leuthold Group LLC’s holdings in McKesson were worth $10,458,000 at the end of the most recent reporting period.
Several other hedge funds also recently bought and sold shares of MCK. RFP Financial Group LLC grew its position in shares of McKesson by 9.8% during the 2nd quarter. RFP Financial Group LLC now owns 191 shares of the company’s stock valued at $112,000 after purchasing an additional 17 shares in the last quarter. Modera Wealth Management LLC grew its position in McKesson by 2.2% during the second quarter. Modera Wealth Management LLC now owns 804 shares of the company’s stock worth $470,000 after buying an additional 17 shares in the last quarter. Larson Financial Group LLC grew its position in McKesson by 1.6% during the second quarter. Larson Financial Group LLC now owns 1,094 shares of the company’s stock worth $639,000 after buying an additional 17 shares in the last quarter. First Western Trust Bank increased its stake in McKesson by 2.0% in the 1st quarter. First Western Trust Bank now owns 913 shares of the company’s stock worth $490,000 after acquiring an additional 18 shares during the last quarter. Finally, Lindbrook Capital LLC raised its holdings in shares of McKesson by 1.7% in the 1st quarter. Lindbrook Capital LLC now owns 1,133 shares of the company’s stock valued at $608,000 after acquiring an additional 19 shares in the last quarter. Hedge funds and other institutional investors own 85.07% of the company’s stock.
Insider Transactions at McKesson
In other McKesson news, CEO Brian S. Tyler sold 3,753 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $561.10, for a total transaction of $2,105,808.30. Following the completion of the transaction, the chief executive officer now owns 78,586 shares of the company’s stock, valued at approximately $44,094,604.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Over the last ninety days, insiders sold 11,259 shares of company stock worth $6,635,492. Company insiders own 0.11% of the company’s stock.
Analyst Upgrades and Downgrades
View Our Latest Stock Report on McKesson
McKesson Price Performance
Shares of MCK stock opened at $511.62 on Thursday. The business has a 50-day moving average of $562.98 and a 200 day moving average of $557.34. The stock has a market capitalization of $66.48 billion, a PE ratio of 22.86, a P/E/G ratio of 1.18 and a beta of 0.44. McKesson Co. has a 1-year low of $428.50 and a 1-year high of $637.51.
McKesson (NYSE:MCK – Get Free Report) last issued its earnings results on Wednesday, August 7th. The company reported $7.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.21 by $0.67. McKesson had a net margin of 0.94% and a negative return on equity of 242.57%. The firm had revenue of $79.28 billion for the quarter, compared to analysts’ expectations of $82.53 billion. During the same quarter last year, the business earned $7.27 earnings per share. The business’s revenue was up 6.4% on a year-over-year basis. Analysts anticipate that McKesson Co. will post 32.11 EPS for the current year.
McKesson Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 1st. Stockholders of record on Monday, September 2nd will be paid a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a dividend yield of 0.56%. This is an increase from McKesson’s previous quarterly dividend of $0.62. The ex-dividend date of this dividend is Friday, August 30th. McKesson’s dividend payout ratio is 12.69%.
McKesson Company Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Featured Articles
- Five stocks we like better than McKesson
- 3 Fintech Stocks With Good 2021 Prospects
- Why General Mills Is the Perfect Hedge for S&P 500 Volatility
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Viking Therapeutics Is Having a Year to Remember: Time to Buy?
- ETF Screener: Uses and Step-by-Step Guide
- Leverage Proven Stock Factors With These Top 3 Smart Beta ETFs
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.